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CholesteatomaAbstract Introduction: Squamous cell carcinoma (SCC) is a rare cancer entity. Only a few cases of
squamous cell carcinoma associated with cholesteatoma have been reported in the literature so far.
Aim: To describe the case of a squamous cell carcinoma associated with a primary acquired cho-
lesteatoma and discuss the management modalities and the outcome of the disease.
Results: We report the case of a 42-year-old man who presented with a chronic otorrhea and a
progressive hearing loss. Otoscopy showed a polypoid external auditory canal. Tonal audiometry
revealed a mixed hearing loss with an air conduction threshold of 60 dB. Tomodensitometry and
MRI showed erosion of the EAC, lysis of the tympanic bone and the second portion of the facial
nerve. Histological examination of the polypoid tissue concluded with a SCC. According to the
Pittsburgh staging system, the tumor was classiﬁed as T4 N0 M0. The patient underwent a subtotal
petrectomy carrying the tumor and sacriﬁcing the facial nerve, a total parotidectomy and a neck
dissection of level II–V lymph nodes. Intraoperatively, the tumor tissue was associated with an attic
cholesteatoma responsible for ossicular chain destruction. A postoperative radiotherapy was deliv-
ered at a dose of 65 Gy. No recurrence or metastases have been reported after a one year follow-up.
Conclusion: SCC of the external auditory canal can mimic cholesteatoma. A precise diagnosis of
the disease is important to predict the treatment outcome. Optimal management relies on early sur-
gery and postoperative radiotherapy, thus offering the greatest chance of cure.
ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
All rights reserved..
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Squamous cell carcinoma (SCC) of the external auditory
canal (EAC) is rare with a prevalence of one per million
people.1,3 It often mimics other disease entities like chronic oti-
tis media and otitis externa making it a diagnostic challenge.
The poor prognosis associated with this carcinoma requires
an aggressive surgical management with adjunctive radiother-
apy. Cholesteatoma, which is a common diagnosis, is a
squamous epithelium trapped in the temporal bone with an
extension tendency. Only a few cases of these two entities
association have been reported so far.1–3
2. Case report
A 42-year-old man, with no past medical history, presented
with a right otorrhea resistant to medical treatment, evolving
for 8 months, associated with tinnitus and gradually progres-
sive hearing loss (Fig. 1).
Otoscopy showed a polypoid external auditory canal
(EAC), a large marginal perforation of the tympanic mem-
brane with an epidermal invagination. The contralateral ear
was normal and nasal endoscopy as well. There was no facial
nerve palsy or vestibular syndrome.
Tonal audiometry revealed a mixed hearing loss with an air
conduction threshold of 60 dB and an air-bone-gap (ABG) of
40 dB (Fig. 1). CT scan of the petrous temporal bone (Fig. 2)
showed erosion of the EAC and opaciﬁcation of the middle ear
space. It also revealed lysis of the tympanic bone and the sec-
ond portion of the facial nerve.
A biopsy of the polypoid tissue was performed and histo-
logical examination concluded to an inﬁltrating squamous cell
carcinoma (SCC) (Fig. 4). Thoracoabdominal computed
tomography (CT) performed for initial staging showed no sec-
ondary lesion. MRI (Fig. 3) demonstrated a soft tissue mass
ﬁlling the EAC with an isosignal intensity on T1 and T2
weighted images. It showed an increased enhancement after
Gadolinium injection, extending to the mastoid region, the
retroauricular soft tissue and the middle ear, without reaching
the temporal fossa. The second portion of the facial nerve was
involved in the mass.Figure 1 Tonal audiometry showing mixedAccording to the Pittsburgh staging system, the tumor was
classiﬁed T4 N0 M0 and the patient was operated on.
Intraoperatively, we discovered an attic cholesteatoma with
an ossicular chain destruction involving the long process of
the uncus and the stapes superstructure.
Our patient underwent a subtotal petrectomy resecting the
tumor, the cholesteatoma and sacriﬁcing the facial nerve
whose second portion was invaded by the mass (Fig. 5).
Total parotidectomy and neck dissection of level II–V lymph
nodes were performed at the same time. The operative cavity
was ﬁlled with abdominal fat. Surgical margins were negative
and deﬁnitive histological examination concluded with a
SCC of the EAC sparing the parotid gland. Histological
assessment of lymph nodes revealed nodal involvement
(1N+/16N).
The postoperative course was uneventful and set apart a
facial palsy. Our patient received a radiation dose of 65 Gy
to the primary tumor site and regional lymph node beds initi-
ated four weeks after surgery. No recurrence or metastases
have been reported after a one year follow-up.
3. Discussion
Squamous cell carcinoma (SCC) is a rare cancer entity
accounting for less than 0.2% of all head and neck cancers
with an incidence of one per million people.3,10 It is the most
common histological type, representing 80% of temporal bone
tumors.6,10,13,17 Cholesteatoma is one form of chronic otitis
characterized by an osteoclastic inﬂammatory process.3 Only
a few cases of squamous cell carcinoma associated with choles-
teatoma have been reported in the literature so far.1–3 Owing
to the low incidence of the disease, publications and reports
in diagnosis and management are rare.10
The peak occurs in the seventh decade of life with a mascu-
line predominance.3,17,19 SCC is easily misdiagnosed. As a
matter of fact, many diseases such as otitis externa, chronic
otitis media and cholesteatoma may lead to confusion with this
pathology.10 In the study of Yin17, 12.6% of patients with SCC
reported a history of chronic otitis media.
Symptoms at initial presentation are usually deafness, otor-
rhea and ear pain.3,25,29 Bloody otorrhea and otalgia are thehearing loss with a mean ABG of 40 dB.
Figure 2 Coronal (a and b) and axial (c and d) CT scan of the right temporal bone showing tympanic bone lysis with opaciﬁcation of the
middle ear space.
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Otoscopy may ﬁnd a fungating mass, a polyp or an invasive
tumor.29
Middle ear polyps extending to the EAC are usually associ-
ated with cholesteatoma. Nevertheless, tumors such as squa-
mous cell carcinomas should be considered in the differential
diagnosis.27
Many authors have implicated cholesteatoma as a causative
factor for squamous cell carcinoma.8,9,26 Bergmann et al.8
detected human papillomavirus (HPV) DNA in 36% of choles-
teatoma using polymerase chain reaction. Histologically,
lesions were characterized by a bone-destructing form with a
papillary growth pattern, as is the case of HPV-associated car-
cinoma in other anatomical sites as well. Watabe-Rudolph9
demonstrated an increased activity of the telomerase in SCC
(66%) compared to cholesteatoma (3.4%). This induces a high
rate of apoptosis in cholesteatoma and an immortal growth of
cancer cells.Some molecular features could also explain progression
from cholesteatoma to SCC. Indeed, Park et al.26 examined
by immunochemical analysis 40 cases of cholesteatoma and
found that survivin was detected in 77% of samples. This pro-
tein, also called baculoviral inhibitor of apoptosis, is abun-
dantly expressed in most solid and hematologic malignancies.
Diagnosis imaging modalities are based on CT scan and
MRI.10,27 They can lead to an early diagnosis and estimate
the extension of the disease.10
CT scan is widely used in the preoperative evaluation of
chronic otitis media. It shows temporal bone erosion and
delineates extension of the lesion.27 MRI may provide useful
information regarding the tumor staging.2,21,27 It is very useful
in showing soft tissue lesion.12 Gadolinium enhancement on
T1 weighted images is seen in benign and malignant tumors,
but not in cholesteatomas. Moreover, diffusion weighted
images seem very promising since they show high intensity
only in cholesteatoma.27
Figure 3 Axial T1-weighted (a), Axial Gadolinium enhanced T1-weighted (b), Axial T2-weighted (c), diffusion sequence (d), Coronal
Gado T1 MRI (e) and Coronal T2-weignted (f): showing a soft tissue mass ﬁlling the EAC with an isosignal intensity on T1 and T2 and an
increased enhancement after Gadolinium injection also on diffusion sequences.
Figure 4 Histological section (HES stain) showing polygonal tumor cells with clear limits, abundant cytoplasm and atypical nuclei.
Stroma is ﬁbro-inﬂammatory with many polynuclear neutrophils. Original magniﬁcation ·40 (a) and ·100 (b).
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radiological ﬁndings, was proposed in 199028 and modiﬁed in
2000.11 It is accurate, reliable and reproducible.3
When CT scan and MRI are suspicious for malignancy,
biopsy is strongly recommended.3,27 It may enhance the diag-
nosis at an early stage and could anticipate insufﬁcient surgery.It should be performed whenever SCC is suspected, espe-
cially if otitis externa or otitis media does not respond to stan-
dard medical treatment.10
Optimal management of SCC remains a matter of
debate.3,10 For most authors, treatment is based on radical
primary surgery and postoperative radiotherapy (RT).3–5
Figure 5 Operative specimen with en-bloc resection of the outer ear and the external auditory canal (a), per operative view (b and c).
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surgery is advocated by most authors as the standard treat-
ment for this disease.6,10,14,15 The aim of this surgery is to
ensure negative margins and minimize morbidity and mortal-
ity.10 Radical surgery is often difﬁcult and incomplete. This is
due to proximity to important organs such as the brain, the
internal carotid artery, the cavernous sinus and the parotid
gland.3
Postoperative radiotherapy plays an important role in local
control.20 Most authors recommend a total dose of 50–70 Gy
to control the disease.7,16,19,23 As metastases are rarely
reported, systemic chemotherapy is not routinely used.3,21
For Yin17, surgery with radiotherapy and/or chemotherapy
was the major treatment for tumors stage III and IV while
chemoradiotherapy was applied when surgery couldn’t have
been performed.
For Hashi23, RT with or without surgery was indicated for
T1-stage disease while surgery was performed for tumors with
bone invasion. Similarly, Ogawa21 recommends RT for T1
tumors, and surgery followed by radiotherapy for T2 and T3
tumors. Nevertheless, others reserve surgery for T1, T2 tumors
and concurrent chemoradiotherapy for T3, T4 tumors.16,19
Prognosis and survival in SCC depends on several factors.17
Facial nerve palsy, late-stage tumor, lymph node involvement,
positive margins, poorly differentiated carcinoma, dural
extension and metastases were associated with poorer
outcome.6,17,20–22,25 Disease free survival rate decreasedsigniﬁcantly with stage from 100% for T1 tumors to 21%
for T4 tumors.6,17,21,25
Early surgery and radiotherapy yields a survival rate of
more than 60% after a median follow up of 7 years compared
with a survival rate of 33% when salvage surgery or RT alone
is performed.6,21,22 Incomplete resection is the most major
cause of recurrence and postoperative RT is not efﬁcient in this
case.18,24 For Ogawa21, patients who were treated with preop-
erative RT tended to have more negative margins than those
treated with postoperative RT. In the same study, the use of
chemotherapy didn’t inﬂuence survival but could enhance
the effect of RT.21 Further studies are required to clarify the
role of chemotherapy in these tumors.21
Local recurrences and metastases are regarded as therapeu-
tic failures.17 High recurrence rate (56%) was reported by
Taguchi19 in patients treated with surgery and RT. Regional
metastases rate varies between 2.5% and 13% according to
some series.11,174. Conclusion
Polyps associated with cholesteatoma are usually considered as
a part of the disease. However, this case report shows that
these polyps may be the tip of an iceberg revealing a malignant
tumor especially a squamous cell carcinoma. Since the
appropriate treatment differs according to the nature of the
274 O.B. Gamra et al.mass lesion, preoperative diagnosis is essential. Early referral
and aggressive primary surgical treatment with postoperative
radiotherapy offer the greatest chance of cure but further stud-
ies are required to deﬁne the optimal management of these
tumors.
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